Refractory Ovarian Carcinoma Recruiting Phase 0 Trials for Platinum (DB12257)

IndicationStatusPhase
DBCOND0110942 (Refractory Ovarian Carcinoma)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04213794Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTreatment